22-5137.Įndo seeks to block government opioid lawsuits during its bankruptcyĮndo files for bankruptcy as u.s. In August, Endo said it had reached a $450 million settlement with more than 30 states to resolve opioid lawsuits. Close High value branded pharmaceutical products. Circuit that the company "has publicly announced that it has ceased research and development of new opioid medications and has not launched a single opioid medication." Endo, a health solutions company, is a US-based diversified healthcare company. intellectual property law.Įndo's lawyers told the D.C. Lamberth said Endo had a "lawful patent monopoly" that was protected under U.S. District Judge Royce Lamberth in March ruled against the agency. Circuit in a filing on Monday that the company "takes no position on the applicability of the bankruptcy code's automatic stay to the instant appeal."Įndo disputed the FTC's claims in the trial court, and U.S. Spokespersons for the FTC and Endo on Friday declined to comment.Ī representative from Impax owner Amneal Pharmaceuticals Inc did not immediately respond to a message seeking comment.Įndo's lawyers at Dechert told the D.C. "The sooner the FTC can secure an injunction against the agreement, the sooner consumers should realize the benefit of lower prices from competitive entry by Endo or third parties," FTC attorneys told the D.C. Circuit, the FTC argued the bankruptcy code's automatic stay provision "does not apply to government enforcement of its police and regulatory power, an exception that applies foursquare to this case." The agency's underlying complaint, filed in 2021, alleged Endo struck a deal with Impax Laboratories LLC in 2017 that curbed competition for extended release oxymorphone. bankruptcy judge to pause hundreds of state and local government lawsuits. law can automatically freeze certain legal actions until bankruptcy proceedings are resolved. The drugmaker filed for bankruptcy amid its effort to resolve more than 3,100 lawsuits over its alleged role in the national opioid epidemic. Circuit to reinstate a briefing schedule in the litigation, after the appeals court in August paused the case pending Endo's Chapter 11 bankruptcy filing in the Southern District of New York. Founded in 1920, the company has its global headquarters located in Dublin. Federal Trade Commission from challenging the dismissal of an antitrust complaint it filed against the pharmaceutical company, the agency told the U.S. Its subsidiaries Endo Pharmaceuticals, Par Pharmaceutical and Paladin Labs. (Reuters) - Endo International PLC's pending bankruptcy should not block the U.S. Endo seeking to resolve thousands of opioid-related lawsuits.Circuit paused agency appeal after Endo's Chapter 11 filing
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |